Listen

Description

A conversation with CEO of Loyal, Celine Halioua—

Celine is the founder and CEO of Loyal for Dogs. Loyal is a company working to develop therapies that treat the underlying causes of aging in dogs. All in hopes of coming at the “human longevity” problem from a different, albeit furrier, angle.

Celine has a background in venture capital, neuroscience, and was once chief of staff to Laura Deming at the Longevity Fund before founding her own startup. Our conversation was as wide-ranging as the difference between a Golden Retriever and a Chihuahua.

We discussed what biotech is, how to build a biotech company, and what the benefits of increased funding in biotech would mean for the future of not just dogs, but humans.

Loyal recently completed its first clinical study and announced a $27 mil funding round.

We also talked about preventative and curative medicine, along with one of Celine’s main reasons why she is playing a part in spearheading the longevity fight, as well as the question of the importance and benefits of socialized healthcare.

We thank Celine for her time, research, and eclectic mind.

Enjoy the conversation, and until next time - Ad Astra!

--

Timestamps:

--

More on Celine Halioua:

Celine’s Website: https://www.celinehh.com/

Celine’s Twitter: @celinehalioua

Loyal’s Website: https://loyalfordogs.com/

Loyal’s Twitter: @loyalfordogs

--

More on Eclectic Spacewalk:

Subscribe to Substack Newsletter

https://eclecticspacewalk.substack.com/



Listen to all podcasts on Anchor

https://anchor.fm/eclecticspacewal



Watch all podcasts on YouTube

https://www.youtube.com/playlist?list...



Follow Eclectic Spacewalk on Twitter

https://twitter.com/ESpacewalk



Eclectic Spacewalk Website

https://www.eclecticspacewalk.com/